Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Denosumab (Primary)
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Amgen
- 26 Jan 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.